Αρχειοθήκη ιστολογίου

Κυριακή 10 Σεπτεμβρίου 2017

Ramucirumab + docetaxel nearly doubles PFS, ORR of urothelial cancer with no impact on QoL in RANGE trial #esmo17 https://t.co/BJvHUG02nw

Ramucirumab + docetaxel nearly doubles PFS, ORR of urothelial cancer with no impact on QoL in RANGE trial #esmo17 https://t.co/BJvHUG02nw

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/906769124923199489
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader